OpenAI has launched GPT-Rosalind, a specialized AI model aimed at accelerating drug discovery and biological research. Named after scientist Rosalind Franklin, known for her work on DNA’s structure, the model scored impressively in bioinformatics benchmarks, outperforming previous models. While it is not intended to replace researchers, it aims to streamline complex scientific processes. Currently, access is limited to U.S. enterprise customers under safety reviews, with notable collaboration partners like Amgen and Moderna. OpenAI also introduced a free plugin for scientific databases to aid broader research access.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.thenews.com.pk/latest/1399486-openai-gptrosalind-ai-model-to-speed-up-drug-discovery
